Shadow people

Shadow people is a visual effect in which dark, featureless humanoid figures are perceived at the periphery or in the direct visual field.

As a drug effect it is acute and high-dose-dependent, fading as the substance wears off; this distinguishes it from hallucinatory experiences associated with psychiatric conditions. It ranges from a fleeting peripheral impression to persistent apparitions that feel unmistakably present, and it is consistently reported as adverse in character.

It is uncommonly reported relative to other drug-induced visual effects. It is most commonly induced at high doses under depressants such as eszopiclone, promethazine, and zolpidem, and in a more fully formed and persistent manner under deliriants such as diphenhydramine, datura, and benzydamine; it also appears at high doses under stimulants such as ephylone, and under psychedelics such as psilocin.

Shadow people is felt as the visual detection of dark, human-shaped figures that carry an unmistakable sense of intentional presence — as though watching or slowly approaching. The figures are typically featureless: no faces, no clothing detail, a uniform darkness against the surrounding environment.

They appear most often in peripheral vision and may retreat when looked at directly, or they may persist and resolve into the central field. Attending to one sharpens awareness of the surrounding space, which can deepen the feeling of being observed. At high doses, particularly under deliriants, the figures may multiply and move with apparent purpose.

Shadow people arises through different pathways depending on the drug class:

• Depressants — z-drugs and sedating compounds at high doses blur the boundary between sleep-state imagery and waking perception, allowing hallucinatory figures to surface into open-eye awareness.
• Deliriants — muscarinic acetylcholine receptor blockade disrupts the brain's capacity to distinguish internally generated images from sensory input; shadow figures are among the most consistent and well-documented deliriant hallucinations.
• Stimulants — sustained excess at high doses produces pattern-detection errors that resolve ambiguous shadows and low-light forms into perceived human figures.
• Psychedelics — 5-HT2A agonism at high doses can generate complex human-form visual constructs.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. It is a high-dose effect and is absent across typical dose ranges. Low light, unfamiliar spaces, and social isolation raise the likelihood considerably — especially under deliriants and z-drugs — as does an anxious disposition or prior history of hallucinatory experience.

Expecting figures in peripheral vision is self-reinforcing: scanning for them tends to find them. Bright, familiar environments with trusted company reduce incidence, and the effect reliably eases as the substance wears off.